Ascendis Pharma A/S
Ascendis Pharma A/S
ASND
Valuace
100
Růst
75
Zdraví
75
Cena
$ 198.90
Dnes
--9.21 (-4.28%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
12.0B
Obrat
1B
Zisk
0B
Aktiva
1B
Dluh
1B
ROE
0%
ROA
0%
PE
-60
PS
19
Cena 1R
118-230
⌀ Cena
187.13
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
11-02-2026
Poslední dividenda

Profil

Společnost Ascendis Pharma A/S, biofarmaceutická společnost, se zaměřuje na vývoj léčebných postupů pro nenaplněné lékařské potřeby. Společnost nabízí přípravek SKYTROFA k léčbě pacientů s nedostatkem růstového hormonu (GHD). Dále vyvíjí TransCon růstový hormon (hGH) pro dětské GHD v Japonsku, TransCon hGH pro dospělé s GHD, TransCon parathormon pro dospělé hypoparatyreózu a TransCon CNP pro dětskou achondroplasii. Kromě toho společnost vyvíjí TransCon mýtné jako receptory 7/8 agonista pro intraumorální porod; a TransCon IL-2 ß/g pro systémový porod. Společnost byla založena v roce 2006 a má sídlo v Hellerup v Dánsku.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
1017
Založení
2015-01-28
Adresa
Tuborg Boulevard 12
CEO
Jan Moller Mikkelsen

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 20252024202320222021202020192018201720162015201420132012
Total Revenues717.8691.7363.6266.751.27.87.013.410.61.54.68.114.020.415.6
Cost of Revenues98.5103.244.344.412.13.50.00.00.00.00.00.00.00.00.0
Gross Profit619.3588.5319.4222.339.04.37.013.410.61.54.68.114.020.415.6
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues245.2213.6158.0101.0173.957.836.095.9137.748.0
Cost of Revenues27.222.431.417.514.011.211.57.619.57.4
Gross Profit218.0191.3126.683.4159.946.624.588.3118.240.6
Operating Income TTM 20252024202320222021202020192018201720162015201420132012
R&D Expenses0.00.00.0413.5379.6295.9260.9191.6140.399.666.040.519.712.711.4
Selling General & Admin Expenses0.00.00.0264.4221.2160.276.748.525.113.511.59.46.32.42.7
Depreciation & Amortization17.717.017.718.934.528.11.79.70.90.70.70.60.50.40.4
Total Operating Expenses755.7719.4598.1677.9600.9456.0337.6240.1165.3113.177.549.926.015.114.1
Operating Income-136.4-130.9-278.8-455.5-561.8-451.8-330.6-226.7-154.8-111.5-72.9-41.8-12.05.31.5
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.090.9111.4
Selling General & Admin Expenses0.00.00.00.00.00.00.00.064.063.6
Depreciation & Amortization4.84.04.34.54.51.72.04.54.84.9
Total Operating Expenses208.2180.3179.5187.6159.5143.4157.8137.5154.9175.1
Operating Income9.811.0-53.0-104.20.4-96.7-133.3-49.1-36.6-134.4
Net Income TTM 20252024202320222021202020192018201720162015201420132012
Interest Income111.114.714.416.952.20.71.817.84.00.90.10.00.00.00.0
Interest Expense158.977.565.544.150.53.91.91.20.10.10.00.00.00.00.0
Other Expense-76.0-73.4-94.5-18.6-16.067.8-88.68.520.4-13.74.18.21.7-0.6-0.2
IBT-212.4-204.3-373.2-474.1-577.8-383.9-419.2-218.3-130.5-124.4-68.7-33.6-10.34.71.3
Income Tax Expense15.314.84.87.35.4-0.4-0.2-0.2-0.4-0.5-0.2-0.7-0.70.60.0
Net Income-227.7-219.0-378.1-481.4-583.2-383.6-419.0-218.0-130.1-123.9-68.5-32.9-9.74.11.3
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income23.83.355.128.9-66.528.349.13.60.04.1
Interest Expense61.419.733.044.8-56.625.319.677.268.624.5
Other Expense-36.3-68.417.910.6-37.8-1.424.1-79.4-44.5-27.2
IBT-26.5-57.4-35.0-93.6-37.4-98.2-109.2-128.5-81.1-161.6
Income Tax Expense6.83.63.81.11.11.00.22.55.80.6
Net Income-33.2-61.0-38.9-94.6-38.5-99.2-109.4-131.0-86.9-162.2
Per Share Data TTM 20252024202320222021202020192018201720162015201420132012
EPS$0.00$0.00$0.00$-8.55$-10.40$-7.00$-8.28$-4.69$-3.17$-3.68$-2.58$-1.39$-0.57$0.38$0.12
EPS Diluted$0.00$0.00$0.00$-8.55$-10.40$-7.00$-8.28$-4.69$-3.17$-3.68$-2.58$-1.39$-0.57$0.38$0.12
Shares Outstanding61.460.657.956.356.154.850.646.541.133.626.623.816.910.810.8
Diluted Shares Outstanding61.460.657.956.356.154.850.646.541.133.626.623.816.910.810.8
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-1.53$-2.88
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-1.53$-2.88
Shares Outstanding61.461.060.560.059.858.657.356.956.656.3
Diluted Shares Outstanding61.461.063.960.059.858.657.356.956.656.3
Current Assets TTM 20242023202220212020201920182017201620152014201320122011
Cash And Equivalents258.8559.5392.2444.8446.3584.5598.1277.9195.4180.3119.650.219.414.515.7
Short Term Investments0.00.07.3290.7235.8134.30.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments258.8559.5399.4735.5682.1718.8598.1277.9195.4180.3119.650.219.414.515.7
Accounts Receivable80.7166.355.825.623.27.35.42.62.41.72.22.41.76.12.0
Inventory251.3295.6208.9130.775.40.00.00.00.00.00.00.00.00.00.0
Other Current Assets36.839.438.631.725.20.00.012.46.92.03.80.60.10.10.3
Total Current Assets627.71,060.9702.7923.5805.9740.1611.2292.9204.6184.0125.753.221.220.718.0
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents539.1494.0517.9559.5625.5258.7320.2392.2441.3394.2
Short Term Investments0.00.00.00.00.00.00.07.314.236.9
Total Cash & ST Investments539.1494.0517.9559.5625.5258.7320.2399.4455.4431.1
Accounts Receivable134.7110.566.7166.333.149.241.135.926.820.2
Inventory302.0303.4293.1295.6265.4251.2232.7208.9189.1167.9
Other Current Assets41.945.143.839.449.768.370.158.561.658.4
Total Current Assets1,017.8953.0921.51,060.9973.7627.3664.1702.7732.9677.7
Long-Term Assets TTM 20242023202220212020201920182017201620152014201320122011
Net Property, Plant & Equipment104.198.7110.6129.1126.0108.145.14.32.62.42.41.92.01.21.3
Goodwill0.03.53.53.53.53.53.53.53.53.53.53.53.53.53.5
Intangible Assets0.00.50.91.31.82.20.00.03.50.00.03.50.00.00.0
Long-Term Investments22.813.65.730.4145.9124.515.517.10.00.00.00.00.00.00.0
Other Long-Term Assets4.22.32.11.91.81.41.51.20.30.30.30.10.00.00.0
Total Long-Term Assets131.1118.6122.9166.3279.0239.765.626.16.36.16.15.55.54.74.8
Total Assets758.71,179.5825.61,089.71,084.9979.8676.7319.0211.0190.1131.858.726.725.422.8
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment101.893.592.498.797.5104.0107.2110.6125.5125.4
Goodwill0.00.00.03.50.00.00.03.50.00.0
Intangible Assets3.73.83.90.54.14.24.30.94.54.6
Long-Term Investments28.334.940.913.616.220.624.85.78.114.1
Other Long-Term Assets3.22.72.72.32.22.22.12.12.12.1
Total Long-Term Assets137.0134.9140.0118.6120.0131.0138.4122.9140.3146.1
Total Assets1,154.81,087.91,061.41,179.51,093.8758.3802.5825.6873.2823.8
Current Liabilities TTM 20242023202220212020201920182017201620152014201320122011
Accounts Payable99.696.494.6101.059.421.927.819.723.813.18.45.02.52.52.5
Short-Term Debt453.9491.525.425.47.06.95.90.00.00.00.00.00.00.20.2
Other Current Liabilities293.5317.875.144.831.323.713.512.30.00.30.00.00.40.00.0
Current Liabilities848.2907.9197.3171.3100.452.848.038.923.813.511.412.920.423.822.4
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable78.693.784.496.475.399.594.594.6121.6122.1
Short-Term Debt482.3462.3490.0491.5449.7453.6439.425.426.326.6
Other Current Liabilities421.4377.1308.4317.8310.9292.2260.575.158.537.8
Current Liabilities986.5935.0885.5907.9838.5847.7799.0197.3212.8192.3
Long-Term Liabilities TTM 20242023202220212020201920182017201620152014201320122011
Long-Term Debt219.2365.1618.9483.098.085.130.70.00.00.00.00.00.00.00.2
Capital Leases0.093.098.80.0105.092.036.60.00.00.00.00.00.00.20.4
Def. Tax Liability7.67.30.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Liabilities1,080.11,285.2971.3826.4201.3141.179.638.923.813.511.412.920.423.822.6
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt331.4330.2357.3365.1338.9219.1229.6618.9639.6479.4
Capital Leases0.090.994.493.089.895.997.898.8104.5103.3
Def. Tax Liability10.39.67.77.38.77.67.15.80.00.0
Total Liabilities1,328.81,275.51,251.21,285.21,191.11,079.41,040.7971.3946.6759.0
Total Common Equity TTM 20242023202220212020201920182017201620152014201320122011
Common Stock7.88.17.77.77.67.26.45.75.04.43.42.31.41.41.4
Retained Earnings0.0-2,559.7-2,277.10.00.00.0-611.3-393.3-263.2159.3111.339.62.1-1.9-3.2
Comprehensive Income-329.11.8-153.4255.7876.0831.5590.7274.4182.213.05.74.02.72.12.0
Total Common Equity-321.3-105.7-145.7263.3883.6838.7597.1280.1187.2176.6120.345.86.31.60.2
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock8.38.28.28.18.17.87.87.77.77.7
Retained Earnings0.0-2,666.4-2,657.6-2,559.7-2,547.4-2,474.2-2,390.9-2,279.0-2,207.8-2,059.3
Comprehensive Income-182.40.31.71.81.00.80.8-153.4-81.257.1
Total Common Equity-174.1-187.6-189.8-105.7-97.3-321.1-238.2-145.7-73.464.8
Other TTM 20242023202220212020201920182017201620152014201320122011
Total Debt673.0856.6644.3508.4105.092.036.60.00.00.00.00.00.00.20.4
Book Value-321.3-105.7-145.7263.3883.6838.7597.1280.1187.2176.6120.345.86.31.60.2
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value-174.1-187.6-189.8-105.7-97.3-321.1-238.2-145.7-73.464.8
Cash Flow From Operating Activities TTM 20252024202320222021202020192018201720162015201420132012
Net Income-490.1-219.0-378.1-481.4-583.2-383.6-419.0-218.0-130.1-123.9-68.5-32.9-9.74.11.3
Depreciation & Amortization18.617.017.718.918.015.49.46.70.90.70.70.60.50.40.4
Stock-Based Compensation50.40.095.566.764.266.853.237.519.79.77.31.71.30.70.1
Change Working Capital-40.968.2-107.2-99.8-18.6-48.9-1.04.11.75.04.1-4.7-7.40.5-2.5
Change In Accounts Receivable-44.715.0-118.6-32.10.00.00.00.00.20.10.80.20.44.0-4.5
Change In Accounts Payable-16.0-10.00.03.50.00.00.00.08.310.84.73.42.60.00.0
Change In Inventories-83.3-5.7-86.7-78.3-55.3-75.40.00.00.0-5.71.6-3.3-0.80.10.6
Other Non-cash Items145.0182.461.021.018.6-67.086.0-5.9-30.513.8-3.5-7.5-2.40.00.0
Cash from Operations-330.10.00.0-467.4-495.7-417.6-271.5-175.9-138.8-95.1-60.2-43.5-18.46.3-0.7
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-33.2-61.0-38.9-94.6-38.5-99.2-109.4-131.0-86.9-162.2
Depreciation & Amortization4.84.04.34.54.54.44.44.55.04.7
Stock-Based Compensation0.030.630.025.626.226.026.017.315.917.2
Change Working Capital38.624.6-44.050.5-44.488.9-22.7-51.8-15.2-24.0
Change In Accounts Receivable-9.1-24.9-48.098.0-124.828.9-11.5-11.3-8.0-14.0
Change In Accounts Payable21.70.00.00.00.00.00.00.0-10.04.5
Change In Inventories0.41.4-10.32.5-30.2-14.2-18.5-23.8-19.8-21.2
Other Non-cash Items57.30.237.4-1.3-36.1-76.240.157.032.939.0
Cash from Operations0.00.00.00.00.00.00.00.0-42.5-124.7
Cash Flow From Investing Activities TTM 20252024202320222021202020192018201720162015201420132012
Capital Expenditure-1.5-8.2-1.4-2.4-14.5-24.2-21.6-5.2-2.6-0.9-0.7-1.0-0.4-1.2-0.3
Acquisitions1.00.00.00.00.0-10.21.70.00.00.00.00.00.00.00.0
Investments-0.10.00.00.0-213.8-226.0-537.80.00.00.00.00.00.00.00.0
Sales of Investment37.10.07.4288.9280.5149.9263.10.00.00.00.00.00.00.00.0
Other Investing Activities7.40.00.00.09.50.03.40.00.00.00.00.00.00.00.0
Cash from Investing36.60.00.0286.561.7-110.6-291.2-5.2-2.6-0.9-0.7-1.0-0.4-1.2-0.3
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-3.3-0.1-4.3-0.7-0.4-0.5-0.3-0.20.1-1.0
Acquisitions0.00.00.00.00.00.00.00.00.00.0
Investments0.00.00.00.00.00.00.00.00.00.0
Sales of Investment0.00.00.00.00.00.00.07.46.623.2
Other Investing Activities0.00.00.00.00.00.00.00.00.00.0
Cash from Investing0.00.00.00.00.00.00.00.06.722.2
Cash Flow From Financing Activities TTM 20252024202320222021202020192018201720162015201420132012
Debt Repaid-11.00.00.0125.8-6.4-6.4-4.80.00.00.00.00.00.0-0.2-0.2
Debt Issued178.1856.6212.4261.7409.819.460.136.60.00.00.00.00.00.00.0
Issuance of Common Stock29.80.00.010.10.0367.9638.8529.3216.4133.1126.0114.147.90.00.0
Repurchase of Common Stock-1.8-16.70.0-1.8-105.3-21.60.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.0-33.10.00.00.00.00.00.00.00.00.0
Other Financing Activities155.60.00.08.5508.444.7-31.4-35.7-13.1-8.4-8.5-8.40.00.00.0
Cash from Financing153.20.00.0134.3396.8351.4602.7493.6203.3124.7117.5105.747.9-0.2-0.2
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.0-6.3137.2
Debt Issued813.721.1-54.7-9.368.0116.03.624.7-15.3297.1
Issuance of Common Stock0.00.00.00.00.00.00.00.01.96.4
Repurchase of Common Stock-0.1-0.60.0-17.40.00.00.00.0-1.80.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.26.2
Cash from Financing0.00.00.00.00.00.00.00.0-6.1143.4
Cash position TTM 20252024202320222021202020192018201720162015201420132012
Net Change in Cash-135.7122.6167.4-52.6-1.5-138.3-13.6320.282.515.060.769.530.74.9-1.1
Closing Cash Balance258.8615.8559.5392.2444.8446.3584.5598.1277.9195.4180.3119.650.219.414.5
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash76.745.0-23.9-41.6-66.0366.8-61.5-71.9-49.147.0
Closing Cash Balance615.8539.1494.0517.9559.5625.5258.7320.2392.2441.3
Free Cash Flow TTM 20252024202320222021202020192018201720162015201420132012
Free Cash Flow-331.543.6-307.6-469.8-510.2-441.9-293.1-181.1-141.5-96.0-60.9-44.5-18.85.1-0.9
Real Free Cash Flow-381.943.6-403.1-536.5-574.4-508.7-346.3-218.6-161.1-105.7-68.2-46.2-20.14.4-1.1
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow67.42.1-11.7-15.0-87.6-56.6-61.7-101.8-42.4-125.7
Real Free Cash Flow67.4-28.5-41.7-40.6-113.8-82.6-87.7-119.1-58.3-142.9
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-59.8-20.9-1.4
P/S19701.59.4
P/B-78.20.25.2
P/FCF-313.5-21.7-1.5
Market cap$12.0$8.2
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %21.5 %0 %
Debt to Income-357.3 %-54.2 %0 %
Debt to Free cash flow-1873.1 %-169.9 %0 %
Interest expense percentage-116.5 %-10.2 %44.7 %
Current ratio1 7.8 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE130.8 %-5.3 %0 %
ROA-19.7 %-36.3 %0 %
CapEx to Revenue1.2 %82.2 %0 %
RaD to Revenue0 %2702.2 %0 %
ROEM705,813.3 67975.7

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin86.3 %94.1 %68.7 %
Operating margin-19 %-3262.5 %35.5 %
Net margin-31.7 %-3173.8 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding61.4 mil 41.9 mil
Employee count1.0 tis 0.4 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader